Search clinical trials for: multiple myeloma

Total 12949 results

Asan Medical Center
JW Pharmaceutical

Completed

Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)

Healthy

Korea, Republic of
Nova Scotia Health Authority
Sanofi

Terminated

Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

Multiple Sclerosis | Bladder Dysfunction

Canada
Children's Mercy Hospital Kansas City

Completed

Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls

Prader-Willi Syndrome
Bristol-Myers Squibb

Completed

A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Chronic Hepatitis C

United States, Puerto Rico
Children's Treatment Network
McMaster University

Completed

Rehabilitation of Children With Multiple Disabilities

Cerebral Palsy | Brain Injury | Autism | Down's Syndrome

Canada
DNage B.V.

Completed

Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome

Cockayne Syndrome

United States
DNage B.V.

Terminated

Observational Study to Assess Natural History in Cockayne Syndrome Patients

Cockayne Syndrome

United States, France, United Kingdom
University Medical Centre Ljubljana
Hyb, d.o.o., Slovenia

Completed

Clinical Investigation of Wireless Transmission of Invasive Blood Pressure Signal

Shock | Atrial Fibrillation | Multiple Trauma | Perioperative/Postoperative Complications
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery

Osteoarthritis | Arthralgia | Pain Assessment
Abbott

Completed

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

Dyslipidemias | Coronary Heart Disease | Mixed Dyslipidemia | Combined (Atherogenic) Dyslipidemia

United States
Eli Lilly and Company

Completed

A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Germany
Charite University, Berlin, Germany

Unknown

Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis (CIS-COHORT)

Multiple Sclerosis, MS | Clinically Isolated Syndrome

Germany
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.

HIV | Pharmacokinetics
Generex Biotechnology Corp.
Hoffmann-La Roche; Nextrials, Inc.; eResearch Technology, Inc.; OSMOS Clinical... and other collaborators

Unknown

Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin

Diabetes Mellitus

United States, Bulgaria, Canada, Ecuador, Poland, Puerto Rico, Romania, Russian Federation, Ukraine
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults.

Schizophrenia
Pfizer

Completed

A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects

Healthy

United States
VIVUS LLC

Completed

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Obesity

United States
Germans Trias i Pujol Hospital

Completed

Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse

Multiple Sclerosis

Spain
Otsuka Beijing Research Institute

Completed

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

Ascites | Hepatic Cirrhosis

China
McNeil Consumer & Specialty Pharmaceuticals, a...

Completed

A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder
Doroana, Maria Manuela, M.D.
Merck Sharp & Dohme LLC; Eurotrials Brasil Consultores Cientificos Ltda

Completed

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

HIV Infections
S. Andrea Hospital
Istituto Superiore di Sanità; Italian Multiple Sclerosis Foundation

Completed

Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis

Multiple Sclerosis

Italy
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

HIV Infections
Janssen-Cilag, S.A.

Terminated

Safety of Rabeprazole in Patients Under Multiple Treatments

Gastroesophageal Reflux | Gastric Ulcer
University of Turku

Unknown

Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Multiple Sclerosis

Finland
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery

Pain | Postoperative Pain
Pfizer
ViiV Healthcare

Completed

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

Healthy Volunteers

United States, Belgium
EpiCept Corporation

Completed

A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy

Neuralgia | Diabetic Peripheral Neuropathy

India
Brown, Theodore R., M.D., MPH

Completed

Ambulation Study in Multiple Sclerosis

Multiple Sclerosis
University Hospital, Strasbourg, France

Completed

Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

Down Syndrome

France
Pfizer

Completed

Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects

Respiratory Tract Infections

United States
Central Texas Neurology Consultants
Genzyme, a Sanofi Company

Unknown

Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients (CAMA-2)

Multiple Sclerosis
Novartis
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)

Multiple Sclerosis

Japan
Hicks, Audrey, Ph.D.
Multiple Sclerosis Society of Canada

Completed

Supported Treadmill Training for Progressive Multiple Sclerosis

Multiple Sclerosis

Canada
Pfizer
Bristol-Myers Squibb

Completed

A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects

Healthy

Singapore, Belgium
University of British Columbia
Children's & Women's Health Centre of British Columbia; Vancouver Foundation; Circle of Care

Terminated

Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC

Exostoses, Multiple Hereditary

Canada
Merz Pharmaceuticals GmbH

Completed

Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects

Healthy

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

Relapsing Remitting Multiple Sclerosis
Xanodyne Pharmaceuticals

Terminated

Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects

Healthy

United States
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers

Healthy

Japan
Teva Neuroscience, Inc.

Completed

A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

Multiple Sclerosis
Taipei Medical University WanFang Hospital

Unknown

Compare the Efficacy of Acupuncture Therapy and Carbamazepine Oral Dosage in Patients With Carpal Tunnel Syndrome by Multiple Excitability Test

Carpal Tunnel Syndrome | Multiple Excitability Test

Taiwan
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Relapse Remitting Multiple Sclerosis
Teva Neuroscience, Inc.

Completed

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Multiple Sclerosis
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Multiple Sclerosis
Hadassah Medical Organization

Completed

The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis Patients

Multiple Sclerosis

Israel
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Relapsing Remitting Multiple Sclerosis
Bayer

Completed

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron (START)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States

3

Subscribe